Jacob Gottlieb studied Economics at Brown University and medicine at New York University Medical School. Gottlieb is also considered Chartered Financial Analyst a designation achieved in 2001. By 2010, he would use Professional Risk Managers’ International Association to be categorized as Professional Risk Manager. His education and credentials have helped him as an entrepreneur with several business ventures. Altium Capital (AC) is the latest venture, but Gottlieb is a founder of Visium Asset Management, LLC, and Balyasny Asset Management, L.P.
AC makes investments in growing companies that work within the healthcare industry. AC has invested in companies such as Oramed Pharmaceuticals (ORMP), Amarin Corporation (AMRN), Oragenics, and Sellas Life Sciences (SLS). AC made 5.6 percent investment in ORMP because the company is developing an oral drug delivery system that delivers medicine to a person with diabetes that would be normally injected. The use of an oral drug delivery system will reduce the risk of infection. AMRN is a company that develops drugs that promotes cardiovascular health. AMRN’s expertise helped them create a prescription drug called Amarin’s Vascepa, and it used to treat hypertriglyceridemia. Oragenics creates tests that are easy to used by a person without medical training. The tests are used to detect life-threatening diseases and conditions. SLS developed Wilms Tumor Protein (WT1)-targeting immunotherapeutic. They also use other drugs to combat one most aggressive cancer, triple negative breast cancer.
Gottlieb not only was an entrepreneur, but he was a portfolio manager and analyst. As an analyst, Gottlieb would spend two years analyzing global healthcare. Visium Asset Management was a hedge fund that Gottlieb founded in 2005. It grew to over $8 billion. It would be in 2016 the fund would face an insider-trading scandal, but Gottlieb was able to avoid scandal. Gottlieb also was able to make contributions and times to in a variety of philanthropic projects that help programs educate youth.
Running a successful investment firm requires high skills in business and also know the different investment strategies. In addition to that, a person requires to know the various challenges that face investors and how to overcome them. Many people see to invest so as to secure their future. However, without proper knowledge and guidance, many people tend to lose money because of investing in the wrong places. Highland Capital Management is a company that has managed to build a great reputation for itself due to its success in the field of investment. Visit jimdondero.com to know more about him.
The company deals with alternative investment management. It mainly focuses on structured investment, hedge funds and also mutual funds. The investment company was founded by two great investors namely; James Dondero who is the head of the company and Mark Okada who works as the CIO of the company. It was founded 26 years ago and since its foundation, the company has greatly developed and has been appreciated by many people. Highland Capital management has its headquarters located in Dallas, Texas in the United States.
The company has recorded a steady growth and is a renowned company all over the world with its offices in different countries around the world such as Sao Paulo, Singapore, Buenos Aires, Seoul, and New York City. Due to its steady growth, the company reported an increase in the income and assets to about $14 billion. It has also greatly provided many people with job opportunities. Some of the investments that are managed by Highland Capital management include; the Highland Floating Rate Opportunities Fund. It was also successful in completing the CLO Value Fund which was used in the invest of secondary CLO debt and equity. The exemplary leadership skills of James Dondero and Mark Okada have made Highland Capital Management become the great company it is by ensuring customer satisfaction in managing their investment assets. Read more at Wikipedia about James Dondero.